The NAFLD group exhibited significantly higher TC, TG, LDL, ALT, BMI, and WBC levels and lower HDL levels than the non-NAFLD group (all p < 0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.